🔗 Share this article

A shadow economy for unlicensed weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking penalties, prosecution or prison.

Platform Response and Material Removal

According to TikTok, the platform has removed violative material and prohibited related keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

Within moments of entering one group, a seller posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, posts display black plastic parcels with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.